HIGHLIGHTS
- who: Maximilian Linxweiler from the Department of Otorhinolaryngology, Head and Neck Surgery, Saarland University Medical Center, Kirrbergerstr100, Building, Homburg/Saar, Germany have published the Article: Complete remission of an early-stage laryngeal cancer under combined pembrolizumab and chemotherapy treatment of a synchronous lung adenocarcinoma, in the Journal: (JOURNAL)
SUMMARY
Immune checkpoint inhibition (ICI) has revolutionized the understanding of cancer biology and systemic cancer therapy and has been implemented in treatment standards of a wide spectrum of hematological and solid human malignancies. An enormous number of ongoing clinical trials is investigating further indications for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.